Study programme
Classes
- Pharmacology I. +2E0106015 | Faculty of Medicine in Pilsen
- Pharmacology II. +2E0107015 | Faculty of Medicine in Pilsen
- Pharmacology +1E0206015 | Faculty of Medicine in Pilsen
- Proteomic Biomarker DiscoveryEAV10002 | Faculty of Medicine in Pilsen
- Pharmacology IEA0106015 | Faculty of Medicine in Pilsen
- Current Issues in PharmacologyEAV10001 | Faculty of Medicine in Pilsen
- ? +13ED1P379 | Faculty of Medicine in Pilsen
- Hydrogel scaffolds for tissue engineeringEDDP257 | Faculty of Medicine in Pilsen
- Current Issues in Pharmacology_CZEVP10001 | Faculty of Medicine in Pilsen
- Vitamin D MetabolismEVP10002 | Faculty of Medicine in Pilsen
Publications
- Perioperative tumour marker levels as prognostic factors for surgical treatment of breast cancer liver metastases2018 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- CEA, CA 15-3, and TPS as Prognostic Factors in the Follow-up Monitoring of Patients After Radical Surgery for Breast Cancer2018 | Faculty of Medicine in Pilsen
- Serum Levels of IGF-1 and IGFBP-3 in Relation to Clinical and Pathobiological Aspects of Head and Neck Squamous Cell Carcinomas2017 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové
- Serum Concentration of Erlotinib and its Correlation with Outcome and Toxicity in Patients with Advanced-stage NSCLC2017 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Faculty of Science
- Prognostic role of serum C-reactive protein in patients with advanced-stage NSCLC treated with pemetrexed2017 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Changes in the expression of N- and O-glycopeptides in patients with colorectal cancer and hepatocellular carcinoma quantified by full-MS scan FT-ICR and multiple reaction monitoring2017 | Faculty of Medicine in Pilsen, Faculty of Science
- Importance of Preoperative Knowledge of the Biomarker HE4 in Early-stage Endometrial Cancer Regarding Surgical Management2017 | Faculty of Medicine in Pilsen
- MIC1/GDF15 as a Bone Metastatic Disease Biomarker2017 | Faculty of Medicine in Pilsen
- Change in Serum Lactate Dehydrogenase Is Associated with Outcome of Patients with Advanced-stage NSCLC Treated with Erlotinib2016 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Faculty of Science
- Pemetrexed Versus Erlotinib in the Second-line Treatment of Patients with Advanced-stage Non-squamous NSCLC Harboring Wild-type EGFR Gene2016 | Faculty of Medicine in Pilsen, Faculty of Science
Loading network view...